Raymond James & Associates lessened its stake in shares of Adtalem Global Education Inc. (NYSE:ATGE – Free Report) by 23.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,794 shares of the company’s stock after selling 6,556 shares during the period. Raymond James & Associates’ holdings in Adtalem Global Education were worth $1,285,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Royal Bank of Canada raised its stake in Adtalem Global Education by 65.2% in the third quarter. Royal Bank of Canada now owns 727 shares of the company’s stock worth $27,000 after buying an additional 287 shares in the last quarter. Ronald Blue Trust Inc. raised its stake in Adtalem Global Education by 336.1% in the third quarter. Ronald Blue Trust Inc. now owns 737 shares of the company’s stock worth $32,000 after buying an additional 568 shares in the last quarter. Lazard Asset Management LLC bought a new position in Adtalem Global Education in the second quarter worth approximately $35,000. Skandinaviska Enskilda Banken AB publ bought a new position in Adtalem Global Education in the third quarter worth approximately $56,000. Finally, US Bancorp DE raised its stake in Adtalem Global Education by 76.7% in the first quarter. US Bancorp DE now owns 1,786 shares of the company’s stock worth $53,000 after buying an additional 775 shares in the last quarter. Institutional investors own 98.84% of the company’s stock.
Adtalem Global Education Price Performance
NYSE ATGE opened at $46.32 on Friday. The firm’s fifty day simple moving average is $48.87 and its two-hundred day simple moving average is $52.51. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 0.51. Adtalem Global Education Inc. has a 12-month low of $33.59 and a 12-month high of $62.99. The firm has a market capitalization of $1.82 billion, a P/E ratio of 16.97, a P/E/G ratio of 0.66 and a beta of 0.92.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on ATGE. StockNews.com downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, February 7th. Barrington Research boosted their price objective on shares of Adtalem Global Education from $55.00 to $65.00 and gave the stock an “outperform” rating in a research note on Friday, January 19th. Four research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Adtalem Global Education presently has a consensus rating of “Buy” and a consensus price target of $56.67.
Check Out Our Latest Report on Adtalem Global Education
About Adtalem Global Education
Adtalem Global Education Inc provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University.
Featured Articles
- Five stocks we like better than Adtalem Global Education
- 3 Healthcare Dividend Stocks to Buy
- Comprehensive Analysis of PayPal Stock
- Most Volatile Stocks, What Investors Need to Know
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Manufacturing Stocks Investing
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding ATGE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adtalem Global Education Inc. (NYSE:ATGE – Free Report).
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.